A systematic review of randomized controlled trials assessing the effect of Vortioxetine on metabolic syndrome risk indicators in patients with depression
Background: The majority of antidepressants have been reported to cause metabolic syndrome (MetS). Paucity of information available for the effect of Vortioxetine on MetS. The study aims to assess the systematic review of Vortioxetine on depressive patients' blood pressure (BP), central obesity...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | Health Sciences Review |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772632023000557 |